AKT1 and neoplasm: TRPV4 elicits cancer progression through inhibition of the tumor suppressor PTEN and upregulation of Akt-ZEB1 signaling, which modulates EMT and aggressiveness [101], while its inhibition leads to cell cycle arrest and induction of apoptosis/autophagy [100].